gnb 바로가기 본문 바로가기
Challenge Bio Further Bio
vision & agenda
The BioPharma Industry Landscape of Post-Covid Era

Changing Risk to Opportunities

We will find out how ‘K-Bio’ can overcome this crisis as an opportunity at a time when the world is in struggle with the COVID-19.

US COVID vaccine, will it succeed

Introduction of current development status of COVID-19 vaccine and treatment in U.S. bio industry and measures the possibility of success.

Development of medication: a Success story

To seek success story of a multinational pharmaceutical company that developed a treatment which saved millions of people from infectious diseases and point out implications for Korean bio companies.